Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adjustable ostomy belt large
23300103002
|
Adjustable ostomy belt large | Belts | Stoma Appliances | No data available |
|
Adjustable ostomy belt medium
23300103001
|
Adjustable ostomy belt medium | Belts | Stoma Appliances | No data available |
|
Adjustable ostomy belt small
23300103000
|
Adjustable ostomy belt small | Belts | Stoma Appliances | No data available |
|
Adjustable web belt 115cm
22903409026
|
Adjustable web belt 115cm | Urinal Systems | Incontinence Appliances | No data available |
|
Adjustable web belt 150cm
22903409028
|
Adjustable web belt 150cm | Urinal Systems | Incontinence Appliances | No data available |
|
Adjustable web belt 95cm
22903409039
|
Adjustable web belt 95cm | Urinal Systems | Incontinence Appliances | No data available |
|
Adjuvanted zoonotic flu vacc (SA, inact) inj 0.5ml pfs
1404000AXAAAAAA
|
Influenza zoonotic H5N8 | Influenza zoonotic H5N8 | Immunological Products and Vaccines | No data available |
|
AdMag 100mg tablets
0101010I0BMACAE
|
AdMag | Magnesium oxide | Gastro-Intestinal System | No data available |
|
AdMag 160mg tablets
0101010I0BMABAL
|
AdMag | Magnesium oxide | Gastro-Intestinal System | No data available |
|
AdMag 400mg tablets
0101010I0BMAABI
|
AdMag | Magnesium oxide | Gastro-Intestinal System | No data available |
|
AdMag heavy 500mg capsules
0101010F0BEAAAU
|
AdMag heavy | Magnesium carbonate | Gastro-Intestinal System | No data available |
|
Adoxal 25mg capsules
090602800BBJWDE
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Adoxal 25mg tablets
090602800BBJVDD
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Adoxal 50mg capsules
090602800BBJXCX
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Adoxal 50mg tablets
090602800BBJYDF
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Adpore dressing 10cm x 35cm
20030100605
|
Adpore dressing 10cm x 35cm | Wound Management & Other Dressings | Dressings | No data available |
|
Adpore Ultra dressing 10cm x 15cm
20030100617
|
Adpore Ultra dressing 10cm x 15cm | Wound Management & Other Dressings | Dressings | No data available |
|
Adpore Ultra dressing 10cm x 30cm
20030100620
|
Adpore Ultra dressing 10cm x 30cm | Wound Management & Other Dressings | Dressings | No data available |
|
Adpore Ultra dressing 7cm x 8cm
20030100615
|
Adpore Ultra dressing 7cm x 8cm | Wound Management & Other Dressings | Dressings | No data available |
|
Adrenaline (base) 1% eye drops
1106000F0AAADAD
|
Adrenaline (Eye) | Adrenaline | Eye | No data available |
|
Adrenaline (base) 100microg/1ml (1 in 10,000) dilute inj pfs
0207030A0AAALAL
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | No data available |
|
Adrenaline (base) 1mg/10ml (1 in 10,000) dilute inj Minijet
0207030A0BBABAB
|
Minjet adrenaline (Sympathomimetic) | Adrenaline | Cardiovascular System | No data available |
|
Adrenaline (base) 1mg/1ml (1 in 1,000) inj Minijet 21 gauge
0304030C0BCADAY
|
Minjet adrenaline (Anaphylactic) | Adrenaline | Respiratory System | No data available |
|
Adrenaline (base) 1mg/1ml (1 in 1,000) inj Minijet 25 gauge
0304030C0BCAFAY
|
Minjet adrenaline (Anaphylactic) | Adrenaline | Respiratory System | No data available |
|
Adrenaline (base) 220micrograms/dose inhaler
0301012A0AAABAB
|
Adrenaline (Asthma) | Adrenaline | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.